SHC3 and breast carcinoma: To further investigate the drug resistance potential of Shc3 in MCF‐7/ADR cells in vivo, we established a xenograft model of multidrug‐resistant breast cancer by subcutaneous inoculation of mice with MCF‐7/ADR‐Vector or MCF‐7/ADR‐Shc3 cells.